NCBI PubMed Central
open access
Real-world cost avoidance associated with bevacizumab biosimilar adoption in a tertiary public hospital in Ecuador: a cost-minimization and budget impact analysis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Methodological Evaluation of Public Health Surveillance Systems in Nigeria Using Difference-in-Differences for Cost-Effectiveness Analysis#174281
- Cost-effectiveness of providing pre-exposure and post-exposure prophylaxis for the prevention of HIV via online pharmacies in western Kenya: a modelling study.#441083
- Valor terapêutico versus valor monetário: análise das inovações farmacêuticas e a precificação de medicamentos no Brasil.#989563
- Targeted versus Universally Offered Screening in Pediatric Emergency Departments: Cost-Effectiveness.#334878
- Additional file 3 of Effectiveness and cost-effectiveness of general health checks in adults: A systematic review#1145936
Record · ID 1236578
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive